Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Systemic contribution of age-associated epigenetic mechanisms to osteoarthritis

Award Number: R01AR075356
ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 09/09/2019
PERIOD OF PERFORMANCE END DATE: 06/30/2025

Group Awards By:

View Award Description

Systemic contribution of age-associated epigenetic mechanisms to osteoarthritis - PROJECT SUMMARY Osteoarthritis (OA) is the most common form of arthritis in the United States and a leading cause of physical disability in older individuals. There are no approved pharmacologic treatments available beyond those for symptomatic relief. Thus, identifying new treatment targets is critical to reducing the burden of OA. While age is one of the strongest predictors of OA, the disease mechanisms that underlie the relationship between cellular and molecular hallmarks of aging and OA are unclear. The long-term goal of this ancillary study is to identify potential new targets for OA therapy by identifying key age-associated biological mechanisms underlying OA pathogenesis. The objective of this project is to determine the role of epigenetic changes to genes in key aging pathways on OA. The central hypothesis is that aging is associated with epigenetic modifications affecting DNA methylation levels in immune blood cells (i.e., `inflammaging') and will be associated with greater burden of disease across commonly affected synovial joints, including the hands, knees and hips. Epigenetic modifications that affect downstream changes in gene and protein expression without altering the DNA sequence may provide important insights into OA pathogenesis that are not captured by information on genetic or environmental risk factors. The contribution of age-related epigenetic mechanisms to OA burden will be assessed in the MOST study, an ongoing well-characterized cohort of individuals with and without early stage knee OA. The pending reexamination of MOST subjects presents a unique, time-sensitive opportunity to obtain contemporaneous measures of epigenetic markers and OA burden that includes assessments of hand OA from radiographs. New acquisition of hand radiographs will be combined with the ongoing radiographic imaging of knees and hips to constitute a multiple joint OA phenotype. The acquisition of hand radiographs and genome-wide DNA methylation will make it possible for the first time in MOST to study the relation of epigenetic factors with multiple joint OA. Aims of the study include 1) determining whether epigenetic age acceleration is associated with multiple joint OA by assessing the difference between chronological age and epigenetic molecular age, then relating this to multiple joint OA and 2) identifying novel epigenetic markers associated with multiple joint OA by performing an epigenome-wide association study, then pathway analyses and hierarchical clustering to identify whether differentially methylated loci and OA subtypes are enriched for biological pathways related to aging. The expected outcome is identification of age-associated epigenetic mechanisms that underlie OA pathogenesis, which is needed to identify relevant OA treatment targets and biomarkers that could be used to identify at-risk individuals earlier in the disease process before the onset of structural changes in the joint. The proposed ancillary study will also provide valuable epigenetics data that will lay the groundwork for future integrative studies of genetics/genomics in the MOST parent study, greatly enhancing its scientific value to the medical community.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $0 )
2025	2022	HEBREW REHABILITATION CENTER	1200 CENTRE ST	ROSLINDALE	MA	02131	SUFFOLK	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	4	9/16/2025	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2022	HEBREW REHABILITATION CENTER	1200 CENTRE ST	ROSLINDALE	MA	02131	SUFFOLK	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	4	7/18/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $425,515 )
2022	2022	HEBREW REHABILITATION CENTER FOR AGED, INC.	1200 CENTRE ST	BOSTON	MA	02131	SUFFOLK	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	4	7/10/2022	NON-COMPETING CONTINUATION	$425,515
														Subtotal = $425,515

Issue Date FY: 2021 ( Subtotal = $417,107 )
2021	2021	HEBREW REHABILITATION CENTER FOR AGED, INC.	1200 CENTRE ST	BOSTON	MA	02131	SUFFOLK	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	3	8/9/2021	NON-COMPETING CONTINUATION	$417,107
														Subtotal = $417,107

Issue Date FY: 2020 ( Subtotal = $420,528 )
2020	2020	HEBREW REHABILITATION CENTER FOR AGED, INC.	1200 CENTRE ST	BOSTON	MA	02131	SUFFOLK	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	2	7/15/2020	NON-COMPETING CONTINUATION	$420,528
														Subtotal = $420,528

Issue Date FY: 2019 ( Subtotal = $463,383 )
2019	2019	HEBREW REHABILITATION CENTER FOR AGED, INC.	1200 CENTRE ST	BOSTON	MA	02131	SUFFOLK	USA	Arthritis, Musculoskeletal and Skin Diseases Research	000	1	9/9/2019	NEW	$463,383
														Subtotal = $463,383

Grand Total All Awards = $1,726,533

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Systemic contribution of age-associated epigenetic mechanisms to osteoarthritis

Award Number: R01AR075356

ORGANIZATION: NATIONAL INSTITUTE OF ARTHRITIS & MUSCULOSKELETAL & SKIN DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 09/09/2019

PERIOD OF PERFORMANCE END DATE: 06/30/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer